Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government decision to change clinical trial methods that put Japanese vaccine developers trailing foreign rivals at a disadvantage. [Read More]

No reproduction or republication without written permission.